文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性呼吸窘迫综合征发病机制与临床前药物研究综述

[A review of studies on the pathogenesis and preclinical drug therapy of acute respiratory distress syndrome].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论综述指出ARDS核心病理为失控炎症反应及肺血管内皮与肺泡上皮屏障损伤,当前药物研发聚焦调控炎症强度与促进屏障修复两条路径。

该综述聚焦急性呼吸窘迫综合征(ARDS),其以非心源性肺水肿和低氧血症为特征,病死率高。近年支持治疗的发展在一定程度上降低了病死率,但治疗费用高、副作用及中重度ARDS高病死率限制了疗效,因此需加强特异性药物研究。文章从失控炎症反应与肺泡上皮及肺血管内皮屏障破坏两方面,汇总近年ARDS发病机制与相关临床前药物研究,为后续治疗提供参考。

要点

  • ARDS以非心源性肺水肿和低氧血症为特征,病死率高。
  • 支持治疗在一定程度上降低了病死率,但治疗费用高、副作用及中重度ARDS高病死率限制其疗效。
  • ARDS核心病理变化为失控的炎症反应及肺血管内皮和肺泡上皮屏障功能受损。
  • 调控炎症反应强度与促进内皮和上皮屏障成为当前ARDS药物治疗的两个关键因素。
  • 文章从失控炎症反应和肺泡上皮与肺血管内皮屏障破坏两方面综述近年ARDS临床前药物研究。

研究设计与关键结果

  • 综述从失控炎症反应及肺泡上皮与肺血管内皮屏障破坏两方面,汇总近年ARDS发病机制与相关临床前药物研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「证据类型、等级与局限」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Acute respiratory distress syndrome (ARDS) is a serious disease with high mortality, which is characterized by non-cardiogenic pulmonary edema and hypoxemia. In recent years, the development of supportive therapy has reduced the mortality to some extent, however, the high cost of treatment, side effects and the high mortality of moderate and severe ARDS limit its efficacy. So it is necessary to strengthen the research on specific drugs. The core pathological changes of ARDS are the uncontrolled inflammatory response and the impairment of pulmonary vascular endothelium and alveolar epithelial barrier function. Therefore, regulating the intensity of inflammatory response and promoting the endothelial and epithelial barrier have become two key factors in the current drug treatment of ARDS. This article summarizes the pathogenesis of ARDS and the related preclinical drug therapy of ARDS in recent years from two aspects: the uncontrolled inflammatory response and the destruction of alveolar epithelial and pulmonary vascular endothelial barrier, in order to provide reference for the later treatment of ARDS.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhou L, Zhang X. [A review of studies on the pathogenesis and preclinical drug therapy of acute respiratory distress syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32386009. doi:10.3760/cma.j.cn121430-20200107-00111

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。